The Beauty Health Company

NasdaqCM:SKIN Stock Report

Market Cap: US$169.9m

Beauty Health Future Growth

Future criteria checks 0/6

Beauty Health is forecast to grow earnings and revenue by 85.4% and 5.1% per annum respectively while EPS is expected to grow by 98.7% per annum.

Key information

85.4%

Earnings growth rate

98.7%

EPS growth rate

Personal Products earnings growth23.9%
Revenue growth rate5.1%
Future return on equityn/a
Analyst coverage

Good

Last updated24 Sep 2024

Recent future growth updates

Recent updates

Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump

Aug 06
Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump

Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?

Jul 16
Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?

Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%

Jun 14
Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%

Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)

May 30
Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)

The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company

Feb 16
The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company

The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion

Jun 19
The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion

Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?

May 28
Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?

At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?

Apr 04
At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?

Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality

Mar 08
Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality

What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?

Jan 01
What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?

An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

Dec 05
An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

The Beauty Health Company: A Compelling Mid To Long-Term Growth Story

Oct 12

Beauty-Health Company announces $200M buyback program

Sep 27

The Beauty Health Q2 2022 Earnings Preview

Aug 08

The Beauty Health Company: Not Looking The Best

Jul 30

Beauty Health: Skincare Today And Alpha Tomorrow

May 13

Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates

May 12
Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates

Earnings and Revenue Growth Forecasts

NasdaqCM:SKIN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264042-11-184
12/31/2025378-26152211
12/31/2024341-29-29-2410
6/30/2024366-84-82N/A
3/31/2024393-81618N/A
12/31/2023398-100-1022N/A
9/30/2023399-84-1122N/A
6/30/2023391-10-63-28N/A
3/31/2023377-7-118-81N/A
12/31/202236644-125-107N/A
9/30/202234620-123-98N/A
6/30/2022325-195-85-66N/A
3/31/2022288-340-86-68N/A
12/31/2021260-379-44-28N/A
9/30/2021220-365-40-32N/A
6/30/2021186-152-40-33N/A
3/31/2021134-23N/AN/AN/A
12/31/2020119-29-16-12N/A
9/30/2020131-19-12-3N/A
12/31/2019167-2-92N/A
12/31/2018112-91-9-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SKIN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SKIN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SKIN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SKIN's revenue (5.1% per year) is forecast to grow slower than the US market (8.8% per year).

High Growth Revenue: SKIN's revenue (5.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SKIN's Return on Equity is forecast to be high in 3 years time


Discover growth companies